Trial Information
High Field (3 Tesla) Magnetic Resonance Spectroscopy Imaging for Follow Up of Prostate Cancer Post Permanent Iodine 125 Brachytherapy Implantation
Inclusion Criteria:
- Suitable candidate for prostate brachytherapy to treat prostate cancer
- Patient signs a study consent form
Exclusion Criteria:
- Have received other radiotherapy for prostate cancer or hormone treatments
- Has contraindication to MRSI scanning
- Does not sign study consent form
Type of Study:
Interventional
Study Design:
Endpoint Classification: Safety/Efficacy Study, Intervention Model: Single Group Assignment, Masking: Open Label, Primary Purpose: Diagnostic
Outcome Measure:
pilot study meant to establish scanning parameters on 3T MRSI
Principal Investigator
Don Yee, MD
Investigator Role:
Principal Investigator
Investigator Affiliation:
Alberta Health Services
Authority:
Canada: Health Canada
Study ID:
NA-15-0003 / 22011
NCT ID:
NCT00126854
Start Date:
October 2005
Completion Date:
April 2011
Related Keywords:
- Prostatic Neoplasm
- brachytherapy
- magnetic resonance spectroscopy
- Neoplasms
- Prostatic Neoplasms
